{{Rsnum
|rsid=967591
|Gene=CD3EAP
|Chromosome=19
|position=45406676
|Orientation=plus
|GMAF=0.2466
|Gene_s=CD3EAP,PPP1R13L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{PMID Auto
|PMID=20061190
|Title=ERCC1 haplotypes modify bladder cancer risk: A case-control study
}}

{{PMID Auto
|PMID=19734419
|Title=A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.
|OA=1
}}

{{PMID Auto
|PMID=21046104
|Title=The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.
}}

{{PMID Auto
|PMID=22335888
|Title=A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.
}}

{{PMID Auto
|PMID=23180017
|Title=PPP1R13L variant associated with prognosis for patients with rectal cancer.
}}

{{PMID Auto
|PMID=23775331
|Title=A functional variant at 19q13.3, rs967591G>A, is associated with shorter survival of early-stage lung cancer.
}}

{{on chip | HumanOmni1Quad}}